{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044986","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.841944+00:00","generated_at":"2026-05-30T00:55:00.098761+00:00","sec_items":["1.01","5.01","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Pulmatrix to merge with Cullgen in reverse merger; Cullgen holders to own 96.4%","bullets":["Pulmatrix to merge with Cullgen; exchange ratio implies Cullgen valuation of $280M, Pulmatrix $10.5M.","Pre-merger Cullgen stockholders to own ~96.4% of combined company; Pulmatrix stockholders ~3.6%.","Pulmatrix plans cash dividend to pre-merger stockholders if net cash exceeds $2.5M at closing.","Combined company board: eight members, seven from Cullgen, one from Pulmatrix.","Closing conditions include stockholder votes, Nasdaq listing, SEC S-4 effectiveness, CSRC approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044986","json":"https://secwatch.observer/filing/0001493152-24-044986.json","markdown":"https://secwatch.observer/filing/0001493152-24-044986.md","text":"https://secwatch.observer/filing/0001493152-24-044986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224044986/0001493152-24-044986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224044986/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:55:00.098761+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}